GGrantIndex
← Leaderboards

Philip M Farrell

University Of Wisconsin Madison

$14,630,012
Attributed
$14,630,012
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.7M · FY200511
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$31,958,153 · 12

By mechanism

M01$17,864,522 · 5
C06$7,000,000 · 5
R01$6,879,240 · 1
R56$214,391 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Wisconsin Madison

Same institution · by research overlap

Others in their field

Top investigators on “Cystic Fibrosis

Research focus

Cystic FibrosisEarly DiagnosisHuman SubjectClinical ResearchTrypsinogenMalnutritionEpidemiologyCost EffectivenessQuality Of LifeNewborn Human (0-6 Weeks)Mass ScreeningPseudomonas AeruginosaDisease /Disorder Proneness /RiskGene MutationOutcomes ResearchInborn Metabolism Disorder DiagnosisGenetic ScreeningEnrollmentEvaluationBiochemicalControl GroupsCostEconomic OutcomeEvolution

Grant awards (35)

Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$502,023
R01 · FY2011 · DK · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$516,616
R01 · FY2010 · DK · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$99,811
R01 · FY2010 · DK · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$508,322
R01 · FY2009 · DK · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$496,723
R01 · FY2008 · DK · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$515,919
R01 · FY2007 · DK · contact PI
ASSESSMENT OF THE BENEFITS, RISKS AND COSTS OF NEONATAL SCREENING FOR CF$7,386
M01 · FY2007 · RR · contact PI
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$214,391
R56 · FY2006 · DK · contact PI
ASSESSMENT OF THE BENEFITS, RISKS AND COSTS OF NEONATAL SCREENING FOR CF$70,639
M01 · FY2006 · RR · contact PI
General Clinical Research Center$1,829,212
M01 · FY2005 · RR
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$794,428
R01 · FY2005 · DK
ASSESSMENT OF THE BENEFITS, RISKS AND COSTS OF NEONATAL SCREENING FOR CF$84,943
M01 · FY2005 · RR
GENERAL CLINICAL RESEARCH CENTER$3,626,014
M01 · FY2004 · RR
EXTRAMURAL FACIL IMPROVEMENT PROG: CANCER &IMMUNOTHERAPY, AIRWAY INFLAMMATION,$1,400,000
C06 · FY2004 · RR
EXTRAMURAL FACIL IMPROVEMENT PROG: BREAST CANCER, GLIOMA$1,400,000
C06 · FY2004 · RR
EXTRAMURAL FACIL IMPROVEMENT PROG: CANCER GENETICS$1,400,000
C06 · FY2004 · RR
EXTRAMURAL FACIL IMPROVEMENT PROG: CANCER: TREATMENT &CHEMOPREVENTION$1,400,000
C06 · FY2004 · RR
EXTRAMURAL FACIL IMPROVEMENT PROG: TUMOGENESIS, ANIMAL MODELS$1,400,000
C06 · FY2004 · RR
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$771,289
R01 · FY2004 · DK
Assessment of the Benefits, Risks and Costs of Neonatal Screening for CF$147,358
M01 · FY2004 · RR
GENERAL CLINICAL RESEARCH CENTER$3,661,786
M01 · FY2003 · RR
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$748,824
R01 · FY2003 · DK
GENERAL CLINICAL RESEARCH CENTER$3,056,231
M01 · FY2002 · RR
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$727,015
R01 · FY2002 · DK
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$106,600
M01 · FY2002 · RR
GENERAL CLINICAL RESEARCH CENTER$2,711,033
M01 · FY2001 · RR
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening$736,052
R01 · FY2001 · DK
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$106,600
M01 · FY2001 · RR
GCRC-CAP-AARON L. CARREL, M.D.$56,475
M01 · FY2001 · RR
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$12,855
M01 · FY2001 · RR
GENERAL CLINICAL RESEARCH CENTER$2,330,577
M01 · FY2000 · RR
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$462,218
R01 · FY2000 · DK
GCRC-CAP-THOMAS WALLHAUS, M.D. (ADDITIONAL TIME)$56,813
M01 · FY2000 · RR
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$0
M01 · FY2000 · RR
PULMONARY BENEFITS OF CYSTIC FIBROSIS NEONATAL SCREENING$0
M01 · FY2000 · RR